Literature DB >> 25057971

A promising light for an impossible disease: miRNAs in malignant gliomas.

Yin Yee Sharon Low1, Wai Hoe Ng.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 25057971      PMCID： PMC6169481          DOI： 10.2217/cns.13.7

Source DB:  PubMed          Journal:  CNS Oncol        ISSN： 2045-0907


× No keyword cloud information.
  21 in total

Review 1.  Gliomas: quo vadis.

Authors:  James T Rutka; Astrid Weyerbrock; Muh Lii Liang
Journal:  Clin Neurosurg       Date:  2006

2.  MicroRNA-181 family predicts response to concomitant chemoradiotherapy with temozolomide in glioblastoma patients.

Authors:  O Slaby; R Lakomy; P Fadrus; R Hrstka; L Kren; E Lzicarova; M Smrcka; M Svoboda; H Dolezalova; J Novakova; D Valik; R Vyzula; J Michalek
Journal:  Neoplasma       Date:  2010       Impact factor: 2.575

Review 3.  MicroRNAs as regulators of neural stem cell-related pathways in glioblastoma multiforme.

Authors:  Pilar González-Gómez; Pilar Sánchez; Helena Mira
Journal:  Mol Neurobiol       Date:  2011-07-05       Impact factor: 5.590

4.  Inhibition of cancer stem cell-like properties and reduced chemoradioresistance of glioblastoma using microRNA145 with cationic polyurethane-short branch PEI.

Authors:  Yi-Ping Yang; Yueh Chien; Guang-Yuh Chiou; Jong-Yuh Cherng; Mong-Lien Wang; Wen-Liang Lo; Yuh-Lih Chang; Pin-I Huang; Yi-Wei Chen; Yang-Hsin Shih; Ming-Teh Chen; Shih-Hwa Chiou
Journal:  Biomaterials       Date:  2011-11-17       Impact factor: 12.479

5.  MicroRNA 21 promotes glioma invasion by targeting matrix metalloproteinase regulators.

Authors:  Galina Gabriely; Thomas Wurdinger; Santosh Kesari; Christine C Esau; Julja Burchard; Peter S Linsley; Anna M Krichevsky
Journal:  Mol Cell Biol       Date:  2008-06-30       Impact factor: 4.272

6.  miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells.

Authors:  Thomas Würdinger; Bakhos A Tannous; Okay Saydam; Johan Skog; Stephan Grau; Jürgen Soutschek; Ralph Weissleder; Xandra O Breakefield; Anna M Krichevsky
Journal:  Cancer Cell       Date:  2008-11-04       Impact factor: 31.743

7.  miR-181d: a predictive glioblastoma biomarker that downregulates MGMT expression.

Authors:  Wei Zhang; Jing Zhang; Katherine Hoadley; Deepa Kushwaha; Valya Ramakrishnan; Shouwei Li; Chunsheng Kang; Yongping You; Chuanlu Jiang; Sonya Wei Song; Tao Jiang; Clark C Chen
Journal:  Neuro Oncol       Date:  2012-05-08       Impact factor: 12.300

8.  MicroRNA and target protein patterns reveal physiopathological features of glioma subtypes.

Authors:  Elodie Lages; Audrey Guttin; Michèle El Atifi; Claire Ramus; Hélène Ipas; Isabelle Dupré; Delphine Rolland; Caroline Salon; Catherine Godfraind; Florence deFraipont; Mehdi Dhobb; Laurent Pelletier; Didier Wion; Emmanuel Gay; François Berger; Jean-Paul Issartel
Journal:  PLoS One       Date:  2011-05-31       Impact factor: 3.240

Review 9.  The 2007 WHO classification of tumours of the central nervous system.

Authors:  David N Louis; Hiroko Ohgaki; Otmar D Wiestler; Webster K Cavenee; Peter C Burger; Anne Jouvet; Bernd W Scheithauer; Paul Kleihues
Journal:  Acta Neuropathol       Date:  2007-07-06       Impact factor: 17.088

10.  miR-124 and miR-137 inhibit proliferation of glioblastoma multiforme cells and induce differentiation of brain tumor stem cells.

Authors:  Joachim Silber; Daniel A Lim; Claudia Petritsch; Anders I Persson; Alika K Maunakea; Mamie Yu; Scott R Vandenberg; David G Ginzinger; C David James; Joseph F Costello; Gabriele Bergers; William A Weiss; Arturo Alvarez-Buylla; J Graeme Hodgson
Journal:  BMC Med       Date:  2008-06-24       Impact factor: 8.775
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.